Annovis Bio Inc. (AMEX:ANVS) changes shares on Tuesday trading session, with a change of 1.05% or $0.06 shares. The trading starts at $5.58 and closed at $5.74 throughout the day. The trading session low price was $5.58 and day high was $5.85 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.14 million while its average volume is 862.43K. In other hand, the ANVS market cap reached to $39.38M.
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -1.19% and up 51.04% for month. Its quarterly performance was 60.22% above, while its half year performance is down -5.23%. ANVS performance fall -39.52% for year-to-date. Current recommendation for Annovis Bio Inc. is 2.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. ANVS EPS (TTM) for 12-month is -0.23. EPS for this year is -20.20%, while for the next year its value is -1.43. Its EPS Q/Q reached -198.10%.
Let’s take a look on the analyst recommendations on ANVS for the current month and previous month. For the current month, 2 of 2 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 1 analysts participate in stock recommendation. Out of 1, 0 rated it sell, 1 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $12.00 – $20.00. Average target price for ANVS was reached at $16.00.
Worth Venture Partners, LLC, Zeke Capital Advisors LLC and Harrison (K.J.) & Partners, Inc. are the top three holders in Annovis Bio Inc. (ANVS) stock. On Mar 30, 2020, Worth Venture Partners, LLC has 0.14 million shares which valued 0.43 million. On Jun 29, 2020, Zeke Capital Advisors LLC owned 27594.0 shares which valued at 0.12 million. On Jun 29, 2020, Harrison (K.J.) & Partners, Inc. has a total of 12000.0 shares which valued at 52200.0. In the end, Harrison (K.J.) & Partners, Inc. have 0.17% shares outstanding of Annovis Bio Inc. (ANVS) on Jun 29, 2020. The insider ownership moved to 37.50% and institutional holding shifted to 10.30%.
The company posted an EPS (TTM) of -0.23. According to the most recent quarter report on (Sep 2020), 1 analysts estimated an average EPS of -0.15. Analyst Estimated EPS for ANVS published in the report was -$0.15 – -$0.15 during the same period.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for ANVS rise 23.56% for period of 200 days. SMA for 50 days was 10.34% which is showing green signal, while SMA-20 was -4.04%. The moving average value for Annovis Bio Inc. (ANVS) is 11.1k and 0.86% for 200 and 50 days respectively.